CAB39 promotes cisplatin resistance in bladder cancer via the LKB1-AMPK-LC3 pathway.
Gao D, Wang R, Gong Y, Yu X, Niu Q, Yang E, Fan G, Ma J, Chen C, Tao Y, Lu J, Wang Z.
Gao D, et al. Among authors: niu q.
Free Radic Biol Med. 2023 Nov 1;208:587-601. doi: 10.1016/j.freeradbiomed.2023.09.017. Epub 2023 Sep 17.
Free Radic Biol Med. 2023.
PMID: 37726090